Close
Nordic 9Nordic 9

Claris Ventures (investor - Venture Capital)

Italy clarisventures.com
See something wrong or missing? Let us know
Offices:Turin

Claris Ventures is a venture capital firm from Italy focused on early-stage investments in high potential biopharma companies.

Average round investment:12.48M USD
Average number per year:2.2
Distribution: 2025 (2)2024 (1)2023 (4)2022 (3)2021 (1)
Portfolio companies: Italy Lever BioItaly IAMA TherapeuticsUnited Kingdom NeoPhore See the entire list
Mostly invests in: Italy Italy (8) Health services (9)
See the entire list

Showing 3 of 11 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Claris Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Claris Ventures

Name Criteria
United Kingdom Origin Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Zeiss
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Starbloom Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States K5 Global
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Canada BoxOne Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Josh Buckley
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Flying Fish Partners
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Civilization Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Pentech
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
China Trend Investment Group
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
Top